C
Charlotte A Larsson
Researcher at Lund University
Publications - 33
Citations - 1068
Charlotte A Larsson is an academic researcher from Lund University. The author has contributed to research in topics: Population & Diabetes mellitus. The author has an hindex of 16, co-authored 33 publications receiving 984 citations. Previous affiliations of Charlotte A Larsson include University of Gothenburg & Malmö University.
Papers
More filters
Journal ArticleDOI
The R28 protein of Streptococcus pyogenes is related to several group B streptococcal surface proteins, confers protective immunity and promotes binding to human epithelial cells
TL;DR: The hypothesis that R28 played a pathogenetic role in the well‐known epidemics of childbed fever (puerperal fever), which were caused by S. pyogenes, is considered.
Journal ArticleDOI
Salivary cortisol differs with age and sex and shows inverse associations with WHR in Swedish women: a cross-sectional study
TL;DR: The findings of generally higher cortisol levels in women than men of all ages are novel and the stronger results seen for Δ-cortisol as opposed to morning cortisol in the association with WHR emphasise the need of studying cortisol variation intra-individually.
Journal ArticleDOI
Polymorphisms in the adiponutrin gene are associated with increased insulin secretion and obesity.
TL;DR: In this article, the association between PNPLA3 variants and obesity was investigated, and their effect on insulin resistance and beta-cell function was also investigated in a Swedish population-based sample (n=1811).
Journal ArticleDOI
Factors Associated with Multiple Medication Use in Different Age Groups
Janne Moen,Karolina Antonov,Charlotte A Larsson,Ulf Lindblad,J. Lars G. Nilsson,Lennart Råstam,Lena Ring +6 more
TL;DR: Multiple medicine use was associated with morbidity and poor self-rated health across all age groups, and female sex and hypertension were associated with multiple medicine use among those aged 30–49 and 50–64 years, current smoking among Those aged 50- to 64 years, and obesity amongThose aged 65–75 years.
Journal ArticleDOI
Protection against experimental infection with group B streptococcus by immunization with a bivalent protein vaccine.
TL;DR: It is shown that a bivalent vaccine, composed of purified Rib and alpha mixed with aluminum hydroxide (alum), an adjuvant accepted for human use, elicits an antibody response to each of the two antigens of Group B streptococcus.